Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06991231 · ClinicalTrials.gov registry record · NA
The Benefits Of Cryoablation In Patients Undergoing Total Knee Arthroplasty
A NA study, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- NA
- Development phase
- 215
- Enrollment target
NCT06991231 is a NA study that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 215 participants.
The verdict
NCT06991231, a NA study, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 215 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the efficacy of cryoablation use on patient-reported outcomes (PROMs) and opioid consumption following total knee arthroplasty. This is a randomized study that will involve a 1:1 randomization to total knee arthroplasty +/- cryoablation.
Interventions
- DEVICE Cryoablation
- PROCEDURE Total knee arthroplasty (TKA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 215 participants |
| Start Date | 2025-06-13 |
| Est. Completion | 2027-01-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06991231
The ClinicalTrials.gov registry entry for NCT06991231 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 215 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cryoablation is the first listed.
NCT06991231 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06991231 about?
NCT06991231 is a clinical study titled "The Benefits Of Cryoablation In Patients Undergoing Total Knee Arthroplasty". The purpose of this study is to evaluate the efficacy of cryoablation use on patient-reported outcomes (PROMs) and opioid consumption following total knee arthroplasty. This is a randomized study that will involve a 1:1 randomization to total knee arthroplasty +/- cryoablation.
What is the current status of trial NCT06991231?
This trial is currently recruiting. It is a NA study. The enrollment target is 215 participants. The study started on 2025-06-13. Estimated completion is 2027-01-01.
What interventions are being tested in trial NCT06991231?
The interventions under investigation include: Cryoablation (DEVICE), Total knee arthroplasty (TKA) (PROCEDURE).
Who is sponsoring clinical trial NCT06991231?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.